Related Experiment Video

Updated: Jun 13, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Synthetic membrane-targeted antibiotics

S K Vooturi1, S M Firestine

  • 1Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy, Wayne State University, Detroit, MI 48201, USA.

Current Medicinal Chemistry
|May 13, 2010
PubMed

Insights

Antimicrobial resistance necessitates novel treatments. This review explores synthetic membrane-bound antibiotics, inspired by natural antimicrobial peptides, as a promising strategy against resistant bacteria.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Antimicrobial resistance (AMR) poses a significant global health threat, driven by evolving bacterial strains like MRSA, VRSA, and VRE.
  • Existing antibiotics face challenges due to resistance, creating an urgent need for novel therapeutic agents targeting new bacterial mechanisms.
  • Membrane-targeting antibiotics, including lipopeptides like daptomycin and natural antimicrobial peptides (AMPs), represent a promising avenue for combating resistant infections.

Purpose of the Study:

  • To review the development of synthetic membrane-bound antibiotics.
  • To highlight synthetic mimetics of antimicrobial peptides (AMPs) as a novel class of antibiotics.
  • To discuss advancements in synthetic membrane-active antibiotics published since 2004.

Main Methods:

  • Literature review of scientific publications since 2004.
  • Analysis of synthetic membrane-bound antibiotics, focusing on AMP mimetics.
  • Discussion of the mechanisms of action and therapeutic potential of these agents.

Main Results:

  • Antimicrobial peptides (AMPs) demonstrate broad-spectrum activity, rapid bactericidal effects, and a low probability of resistance.
  • Synthetic AMP mimetics offer potential advantages, including improved bioavailability and lower manufacturing costs compared to natural AMPs.
  • Research since 2004 has expanded the landscape of synthetic membrane-active antibiotics, offering new therapeutic options.

Conclusions:

  • Synthetic membrane-bound antibiotics, particularly AMP mimetics, are a vital area of research for addressing antimicrobial resistance.
  • These agents offer a promising alternative to conventional antibiotics due to their novel mechanism of action and reduced resistance potential.
  • Continued development of synthetic membrane-active agents is crucial for future antimicrobial therapy.

More Related Videos

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...